DCGI has sought post-market surveillance data from the drugmakers of two fixed-dose combination medicines—Imipramine Hydrochloride IP + Diazepam IP tablets used to ease co-morbid anxiety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback